US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Feb. 17 for "T cell receptors with VGLL1 specificity and uses thereof" (Texas Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,851, issued on Feb. 17, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"T cell receptors with VGLL1 specificity and uses thereof" was invented by Gregory Lizee (Houston) and Cassian Yee (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are tumor-antigen VGLL1 specific T cell receptors. The TCR may be utilized in various therapies, such as autologous cell transplantation, to treat a cancer. Methods for expanding a population of T cells that target VGLL1 are also provided."

The patent was filed on May 21, 2021, under Application No. 17/999,496.

*For further information, including images, chart...